Other
Pain Management
5
Pipeline Programs↗
23
Active Trials↗
6
Companies Involved↗
Pain Management is an early-stage landscape with 5 programs across 6 companies. The most active players are Javelin Pharmaceuticals, Eli Lilly, Milestone Pharmaceuticals Inc.. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 31
Approved
No programs
Analysis
Trial Status
105
clinical trials
Completed50 · 48%
Unknown status15 · 14%
Recruiting12 · 11%
Withdrawn9 · 9%
Terminated7 · 7%
Not yet recruiting7 · 7%
Other5 · 5%
Clinical Trials
Trial Activity
105 trials
Pain Management With Virtual Reality Hypnosis
Recruiting·—·N/A·NCT06502457·142 enrolled
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
Recruiting·—·Phase 4·NCT05898087·128 enrolled
Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population
Recruiting·—·Phase 2·NCT06559215·100 enrolled
Enantyum® IV Versus Piroxen® IM in Emergency Pain Management
Recruiting·—·Phase 3·NCT06404177·300 enrolled
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
Recruiting·—·Phase 3·NCT04979338·640 enrolled
Evaluation of Pain Management After Surgery When Using Nerve Blocks in the Pediatric Population
Not yet recruiting·—·Phase 2·NCT06559137·160 enrolled
Page 1 of 7
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)